Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Tapio Nousiainen"'
Autor:
Matti Vänskä, Irma Koivula, Sari Hämäläinen, Kari Pulkki, Tapio Nousiainen, Esa Jantunen, Auni Juutilainen
Publikováno v:
Haematologica, Vol 96, Iss 9 (2011)
We evaluated pentraxin 3 as a marker for complications of neutropenic fever in 100 hematologic patients receiving intensive chemotherapy. Pentraxin 3 and C-reactive protein were measured at fever onset and then daily to day 3. Bacteremia was observed
Externí odkaz:
https://doaj.org/article/b3c5c0c7cf9f45a7afdf55038a3feab6
Autor:
Ville Varmavuo, Jukka Pelkonen, Jaakko Valtola, Antti Ropponen, Kaija Vasala, Anu Partanen, Marja Pyörälä, Tapio Nousiainen, Hanne Kuitunen, Outi Kuittinen, Leena Keskinen, Esa Jantunen, Tuomas Selander, Karri Penttilä, Pentti Mäntymaa, Lasse Ågren
Publikováno v:
Transfusion. 59:325-334
Background Data are limited on the long-acting granulocyte-colony stimulating factors (G-CSFs) pegfilgrastim (PEG) and lipegfilgrastim (LIPEG) compared with filgrastim (FIL) regarding the mobilization efficiency of CD34+ cells, graft cellular composi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84333ad435f89f312b63cadb45b7723c
https://doi.org/10.1111/trf.14993
https://doi.org/10.1111/trf.14993
Autor:
Pentti Mäntymaa, Tapio Nousiainen, Karri Penttilä, Marja Pyörälä, Kaija Vasala, Lasse Ågren, Esa Jantunen, Jaakko Valtola, Anu Partanen, Ville Varmavuo, Jukka Pelkonen, Antti Ropponen, Tuomas Selander
Publikováno v:
Annals of Hematology. 96:1897-1906
Filgrastim is usually combined with chemotherapy to mobilize hematopoietic progenitor cells in non-Hodgkin lymphoma (NHL) patients. Limited information is available on the efficacy of a preemptive plerixafor (PLER) injection in poor mobilizers after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35559416c46f431b0df5ebe38a91383c
https://doi.org/10.1007/s00277-017-3123-6
https://doi.org/10.1007/s00277-017-3123-6
Autor:
Esa Jantunen, Kaija Vasala, Outi Kuittinen, Matti Isokangas, Susanna Tokola, Tapio Nousiainen, Eila Sonkajärvi, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, Topi Siniluoto, Seppo Alahuhta
Publikováno v:
Journal of Neuro-Oncology. 131:293-300
Primary central nervous system lymphoma (PCNSL) is a rare brain tumour with a dismal prognosis. Several phase II studies with high-dose methotrexate-based regimens have shown promising early results, but in all hospital-based data published so far, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::177e1b16522da0871725d09e7fc54047
https://doi.org/10.1007/s11060-016-2293-8
https://doi.org/10.1007/s11060-016-2293-8
Autor:
Taru Kuittinen, Marja Pyörälä, Raija Silvennoinen, Antti Ropponen, Karri Penttilä, Jaakko Valtola, Tapio Nousiainen, Anne Nihtinen, Pentti Mäntymaa, Päivi Lehtonen, Esa Jantunen, Ville Varmavuo, Jukka Pelkonen, Kaija Vasala, Anu Partanen
Publikováno v:
Transfusion. 55:2358-2368
BACKGROUND Autologous stem cell transplantation is commonly used to treat non-Hodgkin's lymphomas (NHLs). Cellular composition of the blood grafts apparently has a role in the posttransplant hematologic and immune recovery. Plerixafor increases the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fae9bc5a962d2d9f6a8b7d8b43ea0d4
https://doi.org/10.1111/trf.13170
https://doi.org/10.1111/trf.13170
Autor:
Reetta Huttunen, Erkki Elonen, Marjatta Sinisalo, Aarne Kolonen, Riikka Räty, Janne Aittoniemi, Marjut Kauppila, Hannele Rintala, Jaana Syrjänen, Marja Sankelo, Marjaana Säily, Tapio Nousiainen, Heini Huhtala, Esa Jantunen, Hanna Ollikainen, Maija Itälä-Remes, Auvo Rauhala, Pirjo Koistinen
Publikováno v:
Infectious diseases (London, England). 49(11-12)
Infections greatly influence the outcome of acute myeloid leukemia (AML) patients receiving intensive treatment. The aim of this study was to establish the incidence, microbial etiology, risk factors and prognosis of bloodstream infections (BSIs) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5a99e700a594dbe13caae60050d53e5
https://pubmed.ncbi.nlm.nih.gov/28683646
https://pubmed.ncbi.nlm.nih.gov/28683646
Autor:
Sari Hämäläinen, Marja Pyörälä, Ella Mauranen, Jaana Vuopio, Esa Jantunen, Jaana Pentikäinen, Auni Juutilainen, Laura Lindholm, Jori Reijula, Irma Koivula, Tapio Nousiainen
Publikováno v:
Infectious diseases (London, England). 49(8)
Sir,We read with great interest the paper by Campos et al. [1], who described an endemic outbreak of vancomycin-resistant Enterococcus faecium (VRE). VRE is not a common microbiological finding in ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ca7dbc65caad3598ab0d6808296e45e
https://pubmed.ncbi.nlm.nih.gov/24832852
https://pubmed.ncbi.nlm.nih.gov/24832852
Autor:
Hanne Kuitunen, Leena Keskinen, Jaakko Valtola, Pentti Mäntymaa, Outi Kuittinen, Tuomas Selander, Antti Ropponen, Kaija Vasala, Ville Varmavuo, Jukka Pelkonen, Esa Jantunen, Tapio Nousiainen
Publikováno v:
Leukemialymphoma. 57(9)
Limited data is available about the factors affecting early immune recovery or its clinical significance after autologous stem cell transplantation (auto-SCT). We prospectively analyzed factors affecting early immune recovery and outcome among 72 non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09cdfaeb75961b003876f9c08bbf45d4
https://pubmed.ncbi.nlm.nih.gov/26763346
https://pubmed.ncbi.nlm.nih.gov/26763346
Autor:
Ville Varmavuo, Tapio Nousiainen, Taru Kuittinen, Raija Silvennoinen, Esa Jantunen, Pentti Mäntymaa
Publikováno v:
Transfusion. 53:1024-1032
BACKGROUND: Cyclophosphamide (CY) combined with granulocyte–colony-stimulating factor (G-CSF) is commonly used to mobilize stem cells in multiple myeloma (MM). Plerixafor may also be used with G-CSF in patients who mobilize poorly or it may be adde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9eae0af47efbdb7cdd37dd048888977
https://doi.org/10.1111/j.1537-2995.2012.03848.x
https://doi.org/10.1111/j.1537-2995.2012.03848.x
Autor:
Maija Lehtikangas, Anna-Kaisa Purhonen, Matti Vänskä, Esa Jantunen, Tapio Nousiainen, Auni Juutilainen, Taru Kuittinen, Sari Hämäläinen, Irma Koivula, Kari Pulkki
Publikováno v:
Peptides. 36:129-132
Copeptin, the surrogate marker of arginine vasopressin (AVP), has been suggested to be a useful biomarker in monitoring sepsis reflecting hemodynamic imbalance and stress state. This prospective study conducted at a hematology ward in a Finnish Unive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb233aba8ad078a7e9379fb707eb2a43
https://doi.org/10.1016/j.peptides.2012.05.001
https://doi.org/10.1016/j.peptides.2012.05.001